ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

65

P310 An Unusual Association of Idiopathic Syndrome of Inappropriate Antidiuretic Hormone Secretion With Interstitial Lung Disease P311 Relapsing Cryptogenic Organizing Pneumonia: What Comes After Steroids? P312 Restrictions in Diagnosing Lung Diseases; The Importance of Broad Differential P313 Respiratory Bronchiolitis in a Nonsmoker - How Common Is It? P314 Acquired Mounier-Kuhn Syndrome From Idiopathic Pulmonary Fibrosis Presenting With Hemoptysis and Alveolar Hemorrhage P315 Idiopathic Pulmonary Fibrosis, A Finding After COVID-19: A Case Report P316 A Silent Ambush of Lungs: A Rare Case of Organizing Pneumonia Associated With Primary Biliary Cirrhosis P317 When Abdominal Pain and Pseudo-stemi Unleash Paroxysmal Granulomatosis P318 Cryptogenic Organizing Pneumonia in a Rare Miliary Pattern P319 The Complexity of Diagnosing Secondary Organizing Pneumonia P320 Sudden Death of a Patient With Pleuroparenchymal Fibroelastosis P321 Not All Pneumonia Is Infectious: A Case of Diffuse Large B Cell Lymphoma Presenting as Progressive Dyspnea With Features of Organizing Pneumonia P322 Evaluation of Fibroblast Activation Protein-Specific PET/CT in a Patient With Post-COVID Pneumonitis P323 Organizing Pneumonia Presenting as Bilateral Cavitary Lung Disease - An Interesting Discussion P324 Breathless in the Coop: Pigeon Fancier’s Lung Masquerading as Asthma P325 Interstitial Pneumonia With Autoimmune Features Mimicking Paradoxical Responses in a Patient Under Treatment for Tuberculosis: A Case Report P326 A Case of Progressive Post-s-19 Interstitial Lung Disease Requiring Prolonged Hospitalization P327 Atypical Presentation of Acute Exacerbation of Interstitial Lung Disease: A Diagnostic Challenge

BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION A54 EXPLORING ASTHMA AND COPD: DIVERSE INSIGHTS FROM GLOBAL PERSPECTIVES 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P162 Nine Year Trend in the Prevalence of Allergic Diseases and Their Associated Factors in Young Adults P163 The Impact of COVID-19 in Children With a Chronic Lung Disease in Denmark P164 Clinical Presentation and Diagnosis of Respiratory Symptoms During the COVID 19 Pandemic P165 The Effect of Neighborhood-level Opportunity, Vulnerability, and Deprivation on Asthma Outcomes in Children With Severe Asthma P166 Characterizing Adult Asthma: Insights From the Canadian Primary Care Sentinal Surveillance Network P167 Blood Eosinophil Counts in a Population-representative Adult Sample in Western Sweden P168 Asthma Medication Adherence, Control, and Psychological Symptoms: A Hospital-based Study in Saudi Arabia P169 Obesity Prevalence and Association With Lung Function and Clinical Profile of Patients With Chronic Obstructive Pulmonary Disease in Saudi Arabia P170 Unveiling the Clinical Profiles for Patients With Asthma and Chronic Obstructive Pulmonary Disease Starting Single-inhaler Triple Therapy With Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) P172 Real-World Treatment and Exacerbation Patterns Prior to FF/UMEC/VI Initiation Among Patients With Asthma Stepping Up From ICS/LABA in the United States San Diego Convention Center Area B (Hall A-B2, Ground Level)

ATS 2024 Conference Program • San Diego, CA